Kronox Lab Sciences Ltd
₹ 144
-2.35%
23 May
3:12 p.m.
About
Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]
Key Points
- Market Cap ₹ 532 Cr.
- Current Price ₹ 144
- High / Low ₹ 229 / 130
- Stock P/E 20.9
- Book Value ₹ 24.3
- Dividend Yield 0.35 %
- ROCE 43.8 %
- ROE 32.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 24.3% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.9%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
50 | 62 | 82 | 96 | 90 | 100 | |
39 | 48 | 63 | 74 | 62 | 67 | |
Operating Profit | 12 | 15 | 20 | 22 | 28 | 33 |
OPM % | 23% | 24% | 24% | 23% | 32% | 33% |
1 | 1 | 1 | 2 | 2 | 3 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 2 | 2 | 2 | 1 | 1 |
Profit before tax | 12 | 13 | 18 | 22 | 29 | 34 |
Tax % | 27% | 26% | 26% | 26% | 25% | 26% |
9 | 10 | 14 | 16 | 21 | 25 | |
EPS in Rs | 343.60 | 403.73 | 565.56 | 4.42 | 5.75 | 6.86 |
Dividend Payout % | 0% | 0% | 0% | 0% | 9% | 7% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 7% |
TTM: | 12% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 24% |
3 Years: | 23% |
TTM: | 19% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 37% |
3 Years: | 36% |
Last Year: | 33% |
Balance Sheet
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 0.25 | 0.24 | 0.24 | 37 | 37 | 37 |
Reserves | 23 | 27 | 40 | 8 | 29 | 53 |
0 | 4 | 3 | 0 | 0 | 0 | |
11 | 7 | 13 | 9 | 8 | 9 | |
Total Liabilities | 34 | 38 | 57 | 54 | 74 | 99 |
6 | 9 | 11 | 16 | 26 | 28 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 1 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 |
29 | 28 | 45 | 38 | 47 | 70 | |
Total Assets | 34 | 38 | 57 | 54 | 74 | 99 |
Cash Flows
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
4 | 11 | 9 | 20 | 17 | 31 | |
-4 | -3 | -8 | -7 | -17 | -28 | |
-0 | -7 | -1 | -13 | 0 | -2 | |
Net Cash Flow | 0 | 1 | 1 | -0 | 0 | 0 |
Ratios
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 110 | 90 | 114 | 71 | 72 | 72 |
Inventory Days | 70 | 58 | 58 | 61 | 74 | 46 |
Days Payable | 102 | 69 | 89 | 52 | 50 | 52 |
Cash Conversion Cycle | 78 | 79 | 84 | 80 | 96 | 66 |
Working Capital Days | 100 | 100 | 128 | 83 | 143 | 168 |
ROCE % | 50% | 51% | 50% | 52% | 44% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
59s - Newspaper Publicaton for the Audited Financial Results for the Quarter and Year ended on March 31, 2025
- Results- Financial Results For The Quarter And Year Ended On March 31,2025 21h
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 22Nd May, 2025
21h - KRONOX reports FY25 audited results; revenue Rs 10,019L, profit Rs 2,547L; recommends 5% dividend.
-
Board Meeting Intimation for Standalone Financial Results For The Year Ended March 31, 2025
19 May - Board meeting on May 22 to approve FY25 audited results and consider dividend declaration.
-
Intimation Of Withdrawal Of Application Under Regulation 31A Of The SEBI (LODR) Regulations, 2015.
5 May - Withdrawal of promoter reclassification applications by certain members with zero shareholding.
Business Overview:[1][2]
KLSL is in High Purity Speciality Fine Chemicals Business with portfolio of about 185 products including Excipients and ingredients, High Purity Reagents, Pharmaceutical, nutraceutical and Food Chemical.